Atezolizumab Plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

1. Drakaki, A.
2. Powles, T.
3. Bamias, A.
4. Martin-Liberal, J.
5. Shin, S.J.
6. Friedlander, T.
7. Tosi, D.
8. Park, C.
9. Gomez-Roca, C.
10. Lobbedez, F.J.
11. Castellano, D.
12. Morales-Barrera, R.
13. Moreno-Candilejo, I.
14. Fléchon, A.
15. Yuen, K.
16. Rishipathak, D.
17. DuPree, K.
18. Young, F.
19. Michielin, F.
20. Shemesh, C.S.
21. Steinberg, E.E.
22. Williams, P.
23. Lee, J.L.